{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T22:14:30Z","timestamp":1787004870218,"version":"build-2736575974"},"reference-count":102,"publisher":"Georg Thieme Verlag KG","issue":"03","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Semin Liver Dis"],"published-print":{"date-parts":[[2025,9]]},"abstract":"<jats:p>Cirrhosis is an important cause of morbidity and death in patients with chronic liver disease. It can be divided into compensatory and decompensated stages. During the decompensation period, complications such as esophageal and gastric varices hemorrhage, hepatic encephalopathy, infection, and hepatorenal syndrome are often incurred, which has a high mortality rate and leverages huge economic burden on society, healthcare resources, and individuals. Sarcopenia and frailty are common in patients with cirrhosis. The pathogenesis of sarcopenia and frailty in the context of cirrhosis is complicated and multifactorial, including overwhelming systemic inflammation, imbalance of muscle protein metabolism, malnutrition, endocrine and metabolic dysfunctions, intestinal microecological disorders, lack of physical exercise, and other aspects. Notably, accumulating evidence implicates that many patients experience sarcopenia\/frailty even before the onset of liver cirrhosis. In this regard, the magnitude of liver fibrosis is closely linked to the progression of sarcopenia with reciprocal impact. In conclusion, this review article will shed light on the pathogenesis of cirrhosis complicated with sarcopenia\/frailty, aimed at facilitating early diagnosis and effective management.<\/jats:p>","DOI":"10.1055\/a-2564-7551","type":"journal-article","created":{"date-parts":[[2025,4,16]],"date-time":"2025-04-16T19:11:36Z","timestamp":1744830696000},"page":"303-314","source":"Crossref","is-referenced-by-count":3,"title":["The Molecular Pathogenesis of Sarcopenia\/Frailty in Cirrhosis"],"prefix":"10.1055","volume":"45","author":[{"given":"Huanli","family":"Jiao","sequence":"first","affiliation":[{"name":"Department of Health Management, Tianjin Hospital, Hexi District, Tianjin, People's Republic of China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Han","family":"Wang","sequence":"first","affiliation":[{"name":"Department of Health Management, Tianjin Hospital, Hexi District, Tianjin, People's Republic of China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jia","family":"Li","sequence":"first","affiliation":[{"name":"Department of Gastroenterology and Hepatology, Tianjin Medical University General Hospital, Heping District, Tianjin, People's Republic of China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ziyi","family":"Yang","sequence":"first","affiliation":[{"name":"Department of Gastroenterology and Hepatology, Tianjin Medical University General Hospital, Heping District, Tianjin, People's Republic of China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chao","family":"Sun","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology and Hepatology, Tianjin Medical University General Hospital, Heping District, Tianjin, People's Republic of China"},{"name":"Department of Gastroenterology, Tianjin Medical University General Hospital Airport Hospital, Tianjin, People's Republic of China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"194","published-online":{"date-parts":[[2025,4,16]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.1016\/S0140-6736(21)01374-X","article-title":"Liver cirrhosis","volume":"398","author":"P Gin\u00e8s","year":"2021","journal-title":"Lancet"},{"issue":"06","key":"ref2","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1038\/s41575-023-00759-2","article-title":"Global epidemiology of cirrhosis - aetiology, trends and predictions","volume":"20","author":"D Q Huang","year":"2023","journal-title":"Nat Rev Gastroenterol Hepatol"},{"issue":"10","key":"ref3","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1093\/ageing\/afac220","article-title":"Sarcopenia definition, diagnosis and treatment: consensus is growing","volume":"51","author":"A A Sayer","year":"2022","journal-title":"Age Ageing"},{"issue":"03","key":"ref4","doi-asserted-by":"crossref","first-page":"1611","DOI":"10.1002\/hep.32049","article-title":"Malnutrition, frailty, and sarcopenia in patients with cirrhosis: 2021 practice guidance by the American Association for the study of liver diseases","volume":"74","author":"J C Lai","year":"2021","journal-title":"Hepatology"},{"issue":"04","key":"ref5","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1093\/ageing\/afq034","article-title":"Sarcopenia: European consensus on definition and diagnosis: report of the European working group on sarcopenia in older people","volume":"39","author":"A J Cruz-Jentoft","year":"2010","journal-title":"Age Ageing"},{"issue":"1179","key":"ref6","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1093\/postmj\/qgad097","article-title":"Reduced muscle strength is closely linked to computed tomography-defined myosteatosis among inpatients with cirrhosis","volume":"100","author":"C Sun","year":"2023","journal-title":"Postgrad Med J"},{"issue":"04","key":"ref7","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1093\/ageing\/afz046","article-title":"Sarcopenia: revised European consensus on definition and diagnosis","volume":"48","author":"A J Cruz-Jentoft","year":"2019","journal-title":"Age Ageing"},{"issue":"10","key":"ref8","doi-asserted-by":"crossref","first-page":"11","DOI":"10.3390\/nu11102454","article-title":"Controversies in diagnosing sarcopenia in cirrhosis-moving from research to clinical practice","volume":"11","author":"M Sinclair","year":"2019","journal-title":"Nutrients"},{"issue":"01","key":"ref9","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1186\/s12877-023-04309-y","article-title":"Reversing frailty in older adults: a scoping review","volume":"23","author":"A T Kolle","year":"2023","journal-title":"BMC Geriatr"},{"issue":"02","key":"ref10","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1093\/ageing\/afx162","article-title":"Frailty index as a predictor of mortality: a systematic review and meta-analysis","volume":"47","author":"G Kojima","year":"2018","journal-title":"Age Ageing"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1007\/978-3-030-33330-0_3","article-title":"Epidemiology of frailty in older people","volume":"1216","author":"S Rohrmann","year":"2020","journal-title":"Adv Exp Med Biol"},{"issue":"06","key":"ref12","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1016\/j.dld.2018.03.010","article-title":"Frailty and the gut","volume":"50","author":"A Di Sabatino","year":"2018","journal-title":"Dig Liver Dis"},{"key":"ref13","first-page":"55","article-title":"Inflammation, frailty and cardiovascular disease","volume":"1216","author":"P Soysal","year":"2020","journal-title":"Adv Exp Med Biol"},{"issue":"08","key":"ref14","doi-asserted-by":"crossref","first-page":"1629","DOI":"10.1111\/liv.15639","article-title":"Accumulating awareness on the clinical significance and relevance of frailty in cirrhosis: time to dig deeper into mechanistic basis!","volume":"43","author":"Y Deng","year":"2023","journal-title":"Liver Int"},{"issue":"S 01","key":"ref15","doi-asserted-by":"crossref","first-page":"S147","DOI":"10.1016\/j.jhep.2021.01.025","article-title":"Sarcopenia and frailty in decompensated cirrhosis","volume":"75","author":"P Tandon","year":"2021","journal-title":"J Hepatol"},{"issue":"02","key":"ref16","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1007\/s11938-018-0179-x","article-title":"Frailty in patients with cirrhosis","volume":"16","author":"B Kok","year":"2018","journal-title":"Curr Treat Options Gastroenterol"},{"issue":"09","key":"ref17","doi-asserted-by":"crossref","first-page":"e3624","DOI":"10.1210\/clinem\/dgac405","article-title":"The GH\/IGF-1 axis is associated with intrahepatic lipid content and hepatocellular damage in overweight\/obesity","volume":"107","author":"L E Dichtel","year":"2022","journal-title":"J Clin Endocrinol Metab"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"101200","DOI":"10.1016\/j.arr.2020.101200","article-title":"Sarcopenia - molecular mechanisms and open questions","volume":"65","author":"P Wiedmer","year":"2021","journal-title":"Ageing Res Rev"},{"issue":"10","key":"ref19","doi-asserted-by":"crossref","first-page":"9","DOI":"10.3390\/jcm9103239","article-title":"Low serum branched-chain amino acid and insulin-like growth factor-1 levels are associated with sarcopenia and slow gait speed in patients with liver cirrhosis","volume":"9","author":"C Saeki","year":"2020","journal-title":"J Clin Med"},{"issue":"03","key":"ref20","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1016\/S1097-2765(04)00211-4","article-title":"The IGF-1\/PI3K\/Akt pathway prevents expression of muscle atrophy-induced ubiquitin ligases by inhibiting FOXO transcription factors","volume":"14","author":"T N Stitt","year":"2004","journal-title":"Mol Cell"},{"issue":"03","key":"ref21","first-page":"208","article-title":"Type I insulin-like growth factor receptor signaling in skeletal muscle regeneration and hypertrophy","volume":"7","author":"A Philippou","year":"2007","journal-title":"J Musculoskelet Neuronal Interact"},{"issue":"09","key":"ref22","doi-asserted-by":"crossref","first-page":"9","DOI":"10.3390\/cells9091970","article-title":"Mechanisms of IGF-1-mediated regulation of skeletal muscle hypertrophy and atrophy","volume":"9","author":"T Yoshida","year":"2020","journal-title":"Cells"},{"issue":"08","key":"ref23","doi-asserted-by":"crossref","first-page":"910","DOI":"10.1002\/cbin.10466","article-title":"Insulin-like growth factor-1 (IGF-1) promotes myoblast proliferation and skeletal muscle growth of embryonic chickens via the PI3K\/Akt signalling pathway","volume":"39","author":"M Yu","year":"2015","journal-title":"Cell Biol Int"},{"issue":"07","key":"ref24","doi-asserted-by":"crossref","first-page":"1452","DOI":"10.1002\/jcp.24298","article-title":"IGF-1 induces IP3 -dependent calcium signal involved in the regulation of myostatin gene expression mediated by NFAT during myoblast differentiation","volume":"228","author":"J A Vald\u00e9s","year":"2013","journal-title":"J Cell Physiol"},{"issue":"03","key":"ref25","doi-asserted-by":"crossref","first-page":"G241","DOI":"10.1152\/ajpgi.00373.2020","article-title":"Sarcopenia in chronic liver disease: mechanisms and countermeasures","volume":"320","author":"S L Allen","year":"2021","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"issue":"02","key":"ref26","doi-asserted-by":"crossref","first-page":"e14108","DOI":"10.1111\/eci.14108","article-title":"The association of testosterone with sarcopenia and frailty in chronic liver disease","volume":"54","author":"L Chrysavgis","year":"2024","journal-title":"Eur J Clin Invest"},{"issue":"10","key":"ref27","doi-asserted-by":"crossref","first-page":"2358","DOI":"10.1111\/liv.14938","article-title":"Serum testosterone levels and testosterone supplementation in cirrhosis: a systematic review","volume":"41","author":"N Deng","year":"2021","journal-title":"Liver Int"},{"issue":"02","key":"ref28","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1159\/000452499","article-title":"Testosterone deficiency and testosterone treatment in older men","volume":"63","author":"F Saad","year":"2017","journal-title":"Gerontology"},{"issue":"08","key":"ref29","doi-asserted-by":"crossref","first-page":"3024","DOI":"10.1210\/jc.2006-0357","article-title":"Effects of testosterone supplementation on skeletal muscle fiber hypertrophy and satellite cells in community-dwelling older men","volume":"91","author":"I Sinha-Hikim","year":"2006","journal-title":"J Clin Endocrinol Metab"},{"issue":"09","key":"ref30","doi-asserted-by":"crossref","first-page":"1712","DOI":"10.1249\/MSS.0b013e31828cf5f3","article-title":"Testosterone signals through mTOR and androgen receptor to induce muscle hypertrophy","volume":"45","author":"C Basualto-Alarc\u00f3n","year":"2013","journal-title":"Med Sci Sports Exerc"},{"issue":"08","key":"ref31","doi-asserted-by":"crossref","first-page":"3586","DOI":"10.1210\/en.2002-0164","article-title":"Testosterone stimulates intracellular calcium release and mitogen-activated protein kinases via a G protein-coupled receptor in skeletal muscle cells","volume":"144","author":"M Estrada","year":"2003","journal-title":"Endocrinology"},{"issue":"02","key":"ref32","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1210\/en.2009-1177","article-title":"Testosterone supplementation reverses sarcopenia in aging through regulation of myostatin, c-Jun NH2-terminal kinase, Notch, and Akt signaling pathways","volume":"151","author":"E L Kovacheva","year":"2010","journal-title":"Endocrinology"},{"issue":"01","key":"ref33","first-page":"1","article-title":"Relationship between the proteasomal system and autophagy","volume":"4","author":"A Lilienbaum","year":"2013","journal-title":"Int J Biochem Mol Biol"},{"issue":"02","key":"ref34","doi-asserted-by":"crossref","first-page":"307","DOI":"10.4161\/auto.6.2.11137","article-title":"Autophagy inhibition induces atrophy and myopathy in adult skeletal muscles","volume":"6","author":"E Masiero","year":"2010","journal-title":"Autophagy"},{"issue":"01","key":"ref35","doi-asserted-by":"crossref","first-page":"6","DOI":"10.4254\/wjh.v13.i1.6","article-title":"Autophagy in liver diseases","volume":"13","author":"E Kouroumalis","year":"2021","journal-title":"World J Hepatol"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"434","DOI":"10.3389\/fphys.2017.00434","article-title":"Targeting inflammation and downstream protein metabolism in sarcopenia: a brief up-dated description of concurrent exercise and leucine-based multimodal intervention","volume":"8","author":"Z Xia","year":"2017","journal-title":"Front Physiol"},{"issue":"01","key":"ref37","first-page":"12","article-title":"Chronic low-grade inflammation and age-related sarcopenia","volume":"15","author":"I Beyer","year":"2012","journal-title":"Curr Opin Clin Nutr Metab Care"},{"issue":"01","key":"ref38","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1186\/s40001-017-0266-9","article-title":"A study on relationship between elderly sarcopenia and inflammatory factors IL-6 and TNF-\u03b1","volume":"22","author":"A L Bian","year":"2017","journal-title":"Eur J Med Res"},{"issue":"08","key":"ref39","doi-asserted-by":"crossref","first-page":"E983","DOI":"10.1152\/ajpendo.00183.2012","article-title":"Hyperammonemia-mediated autophagy in skeletal muscle contributes to sarcopenia of cirrhosis","volume":"303","author":"J Qiu","year":"2012","journal-title":"Am J Physiol Endocrinol Metab"},{"issue":"06","key":"ref40","doi-asserted-by":"crossref","first-page":"2045","DOI":"10.1002\/hep.29107","article-title":"Ammonia lowering reverses sarcopenia of cirrhosis by restoring skeletal muscle proteostasis","volume":"65","author":"A Kumar","year":"2017","journal-title":"Hepatology"},{"issue":"05","key":"ref41","doi-asserted-by":"crossref","first-page":"e170","DOI":"10.1038\/ctg.2016.33","article-title":"Muscle at risk: the multiple impacts of ammonia on sarcopenia and frailty in cirrhosis","volume":"7","author":"H W Chen","year":"2016","journal-title":"Clin Transl Gastroenterol"},{"issue":"01","key":"ref42","first-page":"30","article-title":"Hyperammonemia and proteostasis in cirrhosis","volume":"21","author":"S Dasarathy","year":"2018","journal-title":"Curr Opin Clin Nutr Metab Care"},{"issue":"06","key":"ref43","first-page":"1213","article-title":"Sarcopenia in chronic liver disease: a metabolic perspective","volume":"10","author":"R Kumar","year":"2022","journal-title":"J Clin Transl Hepatol"},{"issue":"05","key":"ref44","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1016\/j.jhep.2010.08.032","article-title":"Sarcopenia associated with portosystemic shunting is reversed by follistatin","volume":"54","author":"S Dasarathy","year":"2011","journal-title":"J Hepatol"},{"issue":"07","key":"ref45","doi-asserted-by":"crossref","first-page":"879","DOI":"10.4161\/auto.6.7.12753","article-title":"Induction of autophagic flux by amino acid deprivation is distinct from nitrogen starvation-induced macroautophagy","volume":"6","author":"N Ecker","year":"2010","journal-title":"Autophagy"},{"issue":"02","key":"ref46","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1002\/biof.1138","article-title":"Alterations in human muscle protein metabolism with aging: protein and exercise as countermeasures to offset sarcopenia","volume":"40","author":"T A Churchward-Venne","year":"2014","journal-title":"Biofactors"},{"issue":"15","key":"ref47","doi-asserted-by":"crossref","first-page":"21","DOI":"10.3390\/ijms21155254","article-title":"Liver cirrhosis and sarcopenia from the viewpoint of dysbiosis","volume":"21","author":"H Nishikawa","year":"2020","journal-title":"Int J Mol Sci"},{"issue":"05","key":"ref48","doi-asserted-by":"crossref","first-page":"1617","DOI":"10.1053\/gast.1997.v113.pm9352864","article-title":"Growth hormone therapy in patients with cirrhosis: a pilot study of efficacy and safety","volume":"113","author":"A Donaghy","year":"1997","journal-title":"Gastroenterology"},{"issue":"02","key":"ref49","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/j.ecl.2012.04.012","article-title":"Multifaceted role of insulin-like growth factors and mammalian target of rapamycin in skeletal muscle","volume":"41","author":"R A Frost","year":"2012","journal-title":"Endocrinol Metab Clin North Am"},{"issue":"38","key":"ref50","doi-asserted-by":"crossref","first-page":"29900","DOI":"10.1074\/jbc.M003633200","article-title":"Leucine limitation induces autophagy and activation of lysosome-dependent proteolysis in C2C12 myotubes through a mammalian target of rapamycin-independent signaling pathway","volume":"275","author":"S Mordier","year":"2000","journal-title":"J Biol Chem"},{"issue":"02","key":"ref51","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1111\/hepr.12194","article-title":"Clinical significance of therapy using branched-chain amino acid granules in patients with liver cirrhosis and hepatocellular carcinoma","volume":"44","author":"H Nishikawa","year":"2014","journal-title":"Hepatol Res"},{"key":"ref52","doi-asserted-by":"crossref","first-page":"11","DOI":"10.7554\/eLife.80638","article-title":"Association of lithocholic acid with skeletal muscle hypertrophy through TGR5-IGF-1 and skeletal muscle mass in cultured mouse myotubes, chronic liver disease rats and humans","volume":"11","author":"Y Tamai","year":"2022","journal-title":"eLife"},{"issue":"02","key":"ref53","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1055\/s-0029-1211331","article-title":"Glucose metabolism and liver cirrhosis","volume":"103","author":"W Nolte","year":"1995","journal-title":"Exp Clin Endocrinol Diabetes"},{"issue":"04","key":"ref54","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1136\/gut.49.4.557","article-title":"Evidence for altered hepatic gluconeogenesis in patients with cirrhosis using in vivo 31-phosphorus magnetic resonance spectroscopy","volume":"49","author":"K K Changani","year":"2001","journal-title":"Gut"},{"issue":"43","key":"ref55","doi-asserted-by":"crossref","first-page":"7620","DOI":"10.3748\/wjg.v19.i43.7620","article-title":"Branched-chain amino acids in liver diseases","volume":"19","author":"K Tajiri","year":"2013","journal-title":"World J Gastroenterol"},{"issue":"06","key":"ref56","doi-asserted-by":"crossref","first-page":"2018","DOI":"10.1002\/hep.27717","article-title":"Metabolic and molecular responses to leucine-enriched branched chain amino acid supplementation in the skeletal muscle of alcoholic cirrhosis","volume":"61","author":"C Tsien","year":"2015","journal-title":"Hepatology"},{"key":"ref57","doi-asserted-by":"crossref","first-page":"29","DOI":"10.21037\/tgh-20-236","article-title":"Implications of pre-transplant sarcopenia and frailty in patients with non-alcoholic steatohepatitis and alcoholic liver disease","volume":"7","author":"J S Redman","year":"2022","journal-title":"Transl Gastroenterol Hepatol"},{"issue":"10","key":"ref58","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1007\/s00535-019-01605-6","article-title":"Sarcopenia in cirrhosis: from pathogenesis to interventions","volume":"54","author":"M Ebadi","year":"2019","journal-title":"J Gastroenterol"},{"issue":"39","key":"ref59","doi-asserted-by":"crossref","first-page":"14205","DOI":"10.3748\/wjg.v20.i39.14205","article-title":"Oxidative stress, cardiolipin and mitochondrial dysfunction in nonalcoholic fatty liver disease","volume":"20","author":"G Paradies","year":"2014","journal-title":"World J Gastroenterol"},{"issue":"10","key":"ref60","doi-asserted-by":"crossref","first-page":"2288","DOI":"10.1016\/j.biocel.2013.06.024","article-title":"Mitochondrial dysfunction and sarcopenia of aging: from signaling pathways to clinical trials","volume":"45","author":"E Marzetti","year":"2013","journal-title":"Int J Biochem Cell Biol"},{"issue":"01","key":"ref61","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1186\/s12937-025-01081-0","article-title":"Correlation of sarcopenia with progression of liver fibrosis in patients with metabolic dysfunction-associated steatotic liver disease: a study from two cohorts in China and the United States","volume":"24","author":"F Zhang","year":"2025","journal-title":"Nutr J"},{"issue":"11","key":"ref62","doi-asserted-by":"crossref","first-page":"2876","DOI":"10.1016\/j.cgh.2023.02.013","article-title":"Sarcopenia among patients with nonalcoholic fatty liver disease (NAFLD) is associated with advanced fibrosis","volume":"21","author":"M Harring","year":"2023","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"03","key":"ref63","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1002\/hep.28376","article-title":"Sarcopenia is associated with significant liver fibrosis independently of obesity and insulin resistance in nonalcoholic fatty liver disease: nationwide surveys (KNHANES 2008-2011)","volume":"63","author":"Y H Lee","year":"2016","journal-title":"Hepatology"},{"issue":"03","key":"ref64","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1111\/apt.14843","article-title":"Sarcopenia is associated with the risk of significant liver fibrosis in metabolically unhealthy subjects with chronic hepatitis B","volume":"48","author":"E Han","year":"2018","journal-title":"Aliment Pharmacol Ther"},{"issue":"01","key":"ref65","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.jhep.2016.08.019","article-title":"Sarcopenia is an independent risk factor for non-alcoholic steatohepatitis and significant fibrosis","volume":"66","author":"B K Koo","year":"2017","journal-title":"J Hepatol"},{"key":"ref66","doi-asserted-by":"crossref","first-page":"101696","DOI":"10.1016\/j.arr.2022.101696","article-title":"Non-alcoholic fatty liver disease-related fibrosis and sarcopenia: An altered liver-muscle crosstalk leading to increased mortality risk","volume":"80","author":"M S Kuchay","year":"2022","journal-title":"Ageing Res Rev"},{"issue":"01","key":"ref67","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1038\/s41419-020-03353-5","article-title":"Liver fibrosis-induced muscle atrophy is mediated by elevated levels of circulating TNF\u03b1","volume":"12","author":"T Kurosawa","year":"2021","journal-title":"Cell Death Dis"},{"issue":"05","key":"ref68","doi-asserted-by":"crossref","first-page":"1178","DOI":"10.1111\/liv.14358","article-title":"Continued muscle loss increases mortality in cirrhosis: impact of aetiology of liver disease","volume":"40","author":"N Welch","year":"2020","journal-title":"Liver Int"},{"issue":"08","key":"ref69","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.1111\/acer.13425","article-title":"Sarcopenia in alcoholic liver disease: clinical and molecular advances","volume":"41","author":"J Dasarathy","year":"2017","journal-title":"Alcohol Clin Exp Res"},{"issue":"01","key":"ref70","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1172\/JCI88881","article-title":"Liver inflammation and fibrosis","volume":"127","author":"Y Koyama","year":"2017","journal-title":"J Clin Invest"},{"issue":"02","key":"ref71","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1007\/s00424-014-1527-x","article-title":"Current understanding of sarcopenia: possible candidates modulating muscle mass","volume":"467","author":"K Sakuma","year":"2015","journal-title":"Pflugers Arch"},{"key":"ref72","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.3389\/fphys.2017.01045","article-title":"The role of inflammation in age-related sarcopenia","volume":"8","author":"S Dalle","year":"2017","journal-title":"Front Physiol"},{"issue":"01","key":"ref73","doi-asserted-by":"crossref","first-page":"1525","DOI":"10.1515\/med-2021-0364","article-title":"Research progress of gut microbiota and frailty syndrome","volume":"16","author":"X Wang","year":"2021","journal-title":"Open Med (Wars)"},{"issue":"06","key":"ref74","doi-asserted-by":"crossref","first-page":"8","DOI":"10.3390\/nu8060319","article-title":"Crucial role of vitamin D in the musculoskeletal system","volume":"8","author":"E Wintermeyer","year":"2016","journal-title":"Nutrients"},{"issue":"05","key":"ref75","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1111\/hepr.13485","article-title":"Relationship between serum vitamin D level and sarcopenia in chronic liver disease","volume":"50","author":"T Okubo","year":"2020","journal-title":"Hepatol Res"},{"issue":"02","key":"ref76","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/0167-4889(89)90022-0","article-title":"Modulation of DNA synthesis in cultured muscle cells by 1,25-dihydroxyvitamin D-3","volume":"1014","author":"L Drittanti","year":"1989","journal-title":"Biochim Biophys Acta"},{"issue":"08","key":"ref77","doi-asserted-by":"crossref","first-page":"2976","DOI":"10.1210\/en.2011-0159","article-title":"1,25(OH)2vitamin D3 stimulates myogenic differentiation by inhibiting cell proliferation and modulating the expression of promyogenic growth factors and myostatin in C2C12 skeletal muscle cells","volume":"152","author":"L A Garcia","year":"2011","journal-title":"Endocrinology"},{"issue":"01","key":"ref78","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.ydbio.2004.01.046","article-title":"Follistatin complexes myostatin and antagonises myostatin-mediated inhibition of myogenesis","volume":"270","author":"H Amthor","year":"2004","journal-title":"Dev Biol"},{"issue":"16","key":"ref79","doi-asserted-by":"crossref","first-page":"2117","DOI":"10.1042\/CS20200022","article-title":"Cirrhosis and insulin resistance: current knowledge, pathophysiological mechanisms, complications and potential treatments","volume":"134","author":"F Clarembeau","year":"2020","journal-title":"Clin Sci (Lond)"},{"issue":"05","key":"ref80","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1093\/ageing\/afx023","article-title":"Metabolic syndrome and insulin resistance are associated with frailty in older adults: a prospective cohort study","volume":"46","author":"R F P\u00e9rez-Tasigchana","year":"2017","journal-title":"Age Ageing"},{"issue":"07","key":"ref81","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1001\/archinte.167.7.635","article-title":"Insulin resistance and inflammation as precursors of frailty: the cardiovascular health study","volume":"167","author":"J I Barzilay","year":"2007","journal-title":"Arch Intern Med"},{"issue":"19","key":"ref82","doi-asserted-by":"crossref","first-page":"2145","DOI":"10.1001\/archinte.167.19.2145-b","article-title":"Insulin resistance and cognitive decline may be common soil for frailty syndrome","volume":"167","author":"A M Abbatecola","year":"2007","journal-title":"Arch Intern Med"},{"issue":"03","key":"ref83","doi-asserted-by":"crossref","first-page":"270","DOI":"10.3350\/cmh.2019.0015","article-title":"Sarcopenia: ammonia metabolism and hepatic encephalopathy","volume":"25","author":"A Jindal","year":"2019","journal-title":"Clin Mol Hepatol"},{"issue":"02","key":"ref84","doi-asserted-by":"crossref","first-page":"13","DOI":"10.3390\/nu13020540","article-title":"Malnutrition in patients with liver cirrhosis","volume":"13","author":"J Traub","year":"2021","journal-title":"Nutrients"},{"issue":"22","key":"ref85","doi-asserted-by":"crossref","first-page":"14","DOI":"10.3390\/nu14224855","article-title":"The significance of zinc in patients with chronic liver disease","volume":"14","author":"H Nishikawa","year":"2022","journal-title":"Nutrients"},{"key":"ref86","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.nutres.2019.11.009","article-title":"Zinc and protein metabolism in chronic liver diseases","volume":"74","author":"K Katayama","year":"2020","journal-title":"Nutr Res"},{"issue":"03","key":"ref87","doi-asserted-by":"crossref","first-page":"8","DOI":"10.3390\/jcm8030336","article-title":"Serum zinc concentration and sarcopenia: a close linkage in chronic liver diseases","volume":"8","author":"H Nishikawa","year":"2019","journal-title":"J Clin Med"},{"issue":"11","key":"ref88","doi-asserted-by":"crossref","first-page":"2241","DOI":"10.14309\/ajg.0000000000001301","article-title":"Adding branched-chain amino acids to an enhanced standard-of-care treatment improves muscle mass of cirrhotic patients with sarcopenia: a placebo-controlled trial","volume":"116","author":"M Hern\u00e1ndez-Conde","year":"2021","journal-title":"Am J Gastroenterol"},{"issue":"05","key":"ref89","doi-asserted-by":"crossref","first-page":"9","DOI":"10.3390\/jcm9051570","article-title":"Serum zinc level is associated with frailty in chronic liver diseases","volume":"9","author":"H Nishikawa","year":"2020","journal-title":"J Clin Med"},{"issue":"04","key":"ref90","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1080\/07315724.2014.929511","article-title":"Effect of zinc supplementation on GH, IGF1, IGFBP3, OCN, and ALP in non-zinc-deficient children","volume":"34","author":"E D Rocha","year":"2015","journal-title":"J Am Coll Nutr"},{"key":"ref91","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.coi.2014.07.003","article-title":"The cross talk between microbiota and the immune system: metabolites take center stage","volume":"30","author":"H Shapiro","year":"2014","journal-title":"Curr Opin Immunol"},{"issue":"03","key":"ref92","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1159\/000443350","article-title":"Gastrointestinal microbiota and their contribution to healthy aging","volume":"34","author":"A M Mello","year":"2016","journal-title":"Dig Dis"},{"issue":"07","key":"ref93","doi-asserted-by":"crossref","first-page":"11","DOI":"10.3390\/nu11071633","article-title":"Gut microbiota, muscle mass and function in aging: a focus on physical frailty and sarcopenia","volume":"11","author":"A Ticinesi","year":"2019","journal-title":"Nutrients"},{"issue":"12","key":"ref94","doi-asserted-by":"crossref","first-page":"2213","DOI":"10.1136\/gutjnl-2017-315542","article-title":"Age-dependent changes in GI physiology and microbiota: time to reconsider?","volume":"67","author":"R An","year":"2018","journal-title":"Gut"},{"issue":"12","key":"ref95","doi-asserted-by":"crossref","first-page":"1264","DOI":"10.1111\/hepr.12085","article-title":"Physical inactivity and insufficient dietary intake are associated with the frequency of sarcopenia in patients with compensated viral liver cirrhosis","volume":"43","author":"F Hayashi","year":"2013","journal-title":"Hepatol Res"},{"issue":"03","key":"ref96","doi-asserted-by":"crossref","first-page":"e0151652","DOI":"10.1371\/journal.pone.0151652","article-title":"Effects of an exercise programme on functional capacity, body composition and risk of falls in patients with cirrhosis: a randomized clinical trial","volume":"11","author":"E Rom\u00e1n","year":"2016","journal-title":"PLoS One"},{"issue":"11","key":"ref97","doi-asserted-by":"crossref","first-page":"1920","DOI":"10.1016\/j.cgh.2014.04.016","article-title":"Eight weeks of exercise training increases aerobic capacity and muscle mass and reduces fatigue in patients with cirrhosis","volume":"12","author":"L Zenith","year":"2014","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"06","key":"ref98","doi-asserted-by":"crossref","first-page":"1675","DOI":"10.1053\/j.gastro.2019.01.028","article-title":"Frailty associated with waitlist mortality independent of ascites and hepatic encephalopathy in a multicenter study","volume":"156","author":"J C Lai","year":"2019","journal-title":"Gastroenterology"},{"issue":"46","key":"ref99","doi-asserted-by":"crossref","first-page":"6028","DOI":"10.3748\/wjg.v29.i46.6028","article-title":"Frailty in end-stage liver disease: Understanding pathophysiology, tools for assessment, and strategies for management","volume":"29","author":"M Elsheikh","year":"2023","journal-title":"World J Gastroenterol"},{"issue":"07","key":"ref100","doi-asserted-by":"crossref","first-page":"13","DOI":"10.3390\/nu13072349","article-title":"Nutrition and frailty: opportunities for prevention and treatment","volume":"13","author":"M Ni Lochlainn","year":"2021","journal-title":"Nutrients"},{"issue":"02","key":"ref101","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1111\/jgh.16035","article-title":"Home-based intensive nutrition therapy improves frailty and sarcopenia in patients with decompensated cirrhosis: a randomized clinical trial","volume":"38","author":"B L Meena","year":"2023","journal-title":"J Gastroenterol Hepatol"},{"issue":"10","key":"ref102","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1007\/s12603-019-1255-1","article-title":"Serum myostatin and IGF-1 as gender-specific biomarkers of frailty and low muscle mass in community-dwelling older adults","volume":"23","author":"J Chew","year":"2019","journal-title":"J Nutr Health Aging"}],"container-title":["Seminars in Liver Disease"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.thieme-connect.de\/products\/ejournals\/pdf\/10.1055\/a-2564-7551.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,10]],"date-time":"2025-09-10T22:46:55Z","timestamp":1757544415000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.thieme-connect.de\/DOI\/DOI?10.1055\/a-2564-7551"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,16]]},"references-count":102,"journal-issue":{"issue":"03","published-online":{"date-parts":[[2025,9,10]]},"published-print":{"date-parts":[[2025,9]]}},"URL":"https:\/\/doi.org\/10.1055\/a-2564-7551","archive":["Portico","CLOCKSS"],"relation":{},"ISSN":["0272-8087","1098-8971"],"issn-type":[{"value":"0272-8087","type":"print"},{"value":"1098-8971","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,4,16]]}}}